Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Sleep Advances : a Journal of the Sleep Research Society|May 16, 2023
Assessment of morning sleep propensity with lemborexant in adults with insomnia disorder in a randomized, placebo-controlled crossover studyDavid Mayleben, Russell Rosenberg, Kate Pinner, et al.
Human Psychopharmacology|October 2, 2007
Daytime pharmacodynamic and pharmacokinetic evaluation of low-dose sublingual transmucosal zolpidem hemitartrateThomas Roth, David Mayleben, Bruce C Corser, et al.
Sleep|April 13, 2018
A novel forehead temperature-regulating device for insomnia: a randomized clinical trialThomas Roth, David Mayleben, Neil Feldman, et al.
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|February 16, 2021
Comparison of the effect of lemborexant with placebo and zolpidem tartrate extended release on sleep architecture in older adults with insomnia disorderMargaret Moline, Gary Zammit, Jocelyn Y Cheng, et al.
Sleep Medicine|September 4, 2007
Efficacy of the selective extrasynaptic GABA A agonist, gaboxadol, in a model of transient insomnia: a randomized, controlled clinical trialJames K Walsh, David Mayleben, Christine Guico-Pabia, et al.
Annals of Neurology|January 19, 2020
Daridorexant, a New Dual Orexin Receptor Antagonist to Treat Insomnia DisorderYves Dauvilliers, Gary Zammit, Ingo Fietze, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|August 25, 2016
Pharmacodynamic effects of suvorexant and zolpidem on EEG during sleep in healthy subjectsArie Struyk, Cynthia Gargano, Melissa Drexel, et al.
Sleep|April 17, 2010
Nonrestorative sleep as a distinct component of insomniaThomas Roth, Gary Zammit, Alan Lankford, et al.
JAMA Network Open|December 28, 2019
Comparison of Lemborexant With Placebo and Zolpidem Tartrate Extended Release for the Treatment of Older Adults With Insomnia Disorder: A Phase 3 Randomized Clinical TrialRussell Rosenberg, Patricia Murphy, Gary Zammit, et al.
The Journal of Clinical Psychiatry|February 5, 2009
Efficacy and safety of doxepin 1 mg, 3 mg, and 6 mg in elderly patients with primary insomnia: a randomized, double-blind, placebo-controlled crossover studyMartin Scharf, Roberta Rogowski, Steven Hull, et al.
Pageof 2